NCT07172802: A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 102 planned
- Started
- 22 Apr 2025
- Primary completion
- Feb 2027
- Arms
- GI-108
- Results
- None posted
- 22 Apr 2025: Trial started
- 15 Sep 2025: Trial registered